# University of Chicago: Phase 1 study in Lymphoma, B-Cell, Multiple Myeloma (32 participants)

**Score:** 30/100

| Field | Value |
|---|---|
| Sponsor | University of Chicago |
| Sponsor type | Academic and hospital |
| Study | Microbiome Intervention for CAR-T Optimization and Response (MICRO-CART) |
| NCT ID | NCT07871747 |
| Phase | Phase 1 |
| Status | not yet recruiting |
| Conditions | Lymphoma, B-Cell; Multiple Myeloma |
| Intervention types | drug |
| Target enrollment | 32 |
| Site countries | United States |
| Posted | 2026-10-13 |
| Planned start | 2027-02-23 |
| Event | Newly registered study |
| Event date | 2026-10-13 |

## Why this score
- Not yet recruiting: vendors still being chosen.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07871747). Last refreshed: 2026-11-05T08:46:16.625Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.